ROYAL LONDON ASSET MANAGEMENT LTD - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL LONDON ASSET MANAGEMENT LTD ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$604,000
-98.4%
22,783
-75.8%
0.01%
-86.1%
Q4 2014$38,252,000
+976.0%
94,100
-5.5%
0.07%
-19.1%
Q3 2014$3,555,000
+19.6%
99,6000.0%0.09%
+30.9%
Q2 2014$2,972,000
+11.9%
99,600
+15.0%
0.07%
+9.7%
Q1 2014$2,656,00086,6000.06%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders